v3.26.1
ASSET ACQUISITION (Details Textual) - Share Purchase Agreement [Member]
$ / shares in Units, $ in Thousands
1 Months Ended
Mar. 25, 2026
USD ($)
$ / shares
shares
Asset Acquisition Of Oratech Pharmaceuticals Ltd [Member]  
Asset Acquisition [Line Items]  
Number of shares issued | shares 1,250,363
Warrants to purchase ordinary shares | shares 1,006,113
Asset Acquisition Of Oratech Pharmaceuticals Ltd [Member] | Warrant [Member]  
Asset Acquisition [Line Items]  
Number of shares issued | shares 1,296,296
Per share price of shares issued | $ / shares $ 5.4
Asset Acquisition Of Oratech Pharmaceuticals Ltd [Member]  
Asset Acquisition [Line Items]  
Consideration transferred $ 12,422
Cash payment 6,500
Prepaid clinical trial services asset 975
Consideration transferred of intellectual property $ 5,900